Brief: Diasorin Q3 Adj. EBITDA At EUR 94 Mln
Nov 5 (Reuters) - DiaSorin SpA DIAS.MI :
* Q3 NET PROFIT EUR 45 MILLION
* Q3 ADJUSTED EBITDA EUR 94 MILLION
* Q3 REVENUE EUR 287 MILLION
* SEES FOR 2024 EX-COVID REVENUES ABOUT +7% (COVID REVENUES
ABOUT
EUR 30 MILLION
* CONFIRMS FOR 2024 ADJUSTED EBITDA MARGIN AROUND 33%
Further company coverage: DIAS.MI
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21